Effectiveness of neurolysis as a treatment for complications of leprosy neuritis: a systematic review.

BACKGROUND: Complications of leprosy neuritis are considered serious and apparent, with the potential to disable and/or limit individuals. These complications affect not only a patient's physical functioning, but also their family and social lives, while directly impacting the ability to work and/or maintain financial independence, subsequently interfering with their overall quality of life. The present review, therefore, aimed to analyze the effectiveness of neurolysis as an alternative treatment for the complications associated with leprosy neuritis. METHODS: The present review was performed based on the Joanna Briggs Institute methodology, in an effort to answer the following research question: what is the effectiveness of neurolysis as a treatment for leprosy neuritis complications? This research question was defined using the patient-intervention-outcome (PIO) framework, where leprosy represents 'P', neurolysis for 'I', and neuropathic pain/motor function/sensorial function/physical disability/quality of life for 'O'. Randomized and non-randomized clinical trials and prospective observational cohort studies were included in the present review, with no time or date restrictions. RESULTS: The present review included 1 randomized clinical trial and 10 prospective studies, published between 1976 and 2020. All of the outcomes showed improvement, with relief from neuropathic pain being the primary finding. CONCLUSIONS: The evidence obtained in the present review suggested that neurolysis is an effective alternative for the treatment of physical disabilities, the recovery of sensory and motor function, the restoration of quality of life, and neuropathic pain relief.

Clinicopathological features and prognosis of pyoderma gangrenosum in Korea: A single centre, retrospective, observational study over 20 years.

BACKGROUND: Pyoderma gangrenosum is a rare autoinflammatory neutrophilic dermatosis that rapidly evolves. However, little is known about the clinicopathological features and prognosis of pyoderma gangrenosum. AIMS: We aimed to document clinicopathologic and prognostic data of the patients with pyoderma gangrenosum. METHODS: In this retrospective observational study, we reviewed case records of patients diagnosed with pyoderma gangrenosum between 1999-2019. RESULTS: Fifty-three patients were identified by reviewing medical records for skin biopsy; of these, 37 were men and 16 were women. Mean age at onset was 43.3 ± 18.5 years. The most frequently affected area was the lower extremities (60.4%), followed by the head and neck (17.0%). The most common subtype was ulcerative (47.2%), followed by bullous (22.6%). 30 cases had underlying diseases and the most common were malignancy (24.5%), followed by inflammatory bowel diseases (18.9%). The proportion of cases with history of trauma were significantly higher in post-operative type (100%) as compared to the bullous type (8.3%). Histologic features of granulation tissue were frequently found in post-operative type (66.7%) and bullous type (58.3%). Granulomas were predominantly found in bullous type (58.3%). Age <60 years appeared to be significantly associated with multiple lesions. Partial-to-complete remission was observed in 40 cases (75.5%). Nine (17.0%) cases experienced recurrence with a median progression-free period of six months (interquartile range of 3.0-9.0 months). Cases with underlying hematologic disorders and the bullous subtype were significantly associated with early recurrence. LIMITATIONS: This study was a single-centre study with a retrospective design. CONCLUSION: Pyoderma gangrenosum appears to have ethnic differences. Underlying haematologic disorders and bullous subtype have a worse prognosis. However, the type of histopathology did not correlate with the clinical outcome of pyoderma gangrenosum.

Estimation of conditional and marginal odds ratios using the prognostic score.

Introduced by Hansen in 2008, the prognostic score (PGS) has been presented as 'the prognostic analogue of the propensity score' (PPS). PPS-based methods are intended to estimate marginal effects. Most previous studies evaluated the performance of existing PGS-based methods (adjustment, stratification and matching using the PGS) in situations in which the theoretical conditional and marginal effects are equal (i.e., collapsible situations). To support the use of PGS framework as an alternative to the PPS framework, applied researchers must have reliable information about the type of treatment effect estimated by each method. We propose four new PGS-based methods, each developed to estimate a specific type of treatment effect. We evaluated the ability of existing and new PGS-based methods to estimate the conditional treatment effect (CTE), the (marginal) average treatment effect on the whole population (ATE), and the (marginal) average treatment effect on the treated population (ATT), when the odds ratio (a non-collapsible estimator) is the measure of interest. The performance of PGS-based methods was assessed by Monte Carlo simulations and compared with PPS-based methods and multivariate regression analysis. Existing PGS-based methods did not allow for estimating the ATE and showed unacceptable performance when the proportion of exposed subjects was large. When estimating marginal effects, PPS-based methods were too conservative, whereas the new PGS-based methods performed better with low prevalence of exposure, and had coverages closer to the nominal value. When estimating CTE, the new PGS-based methods performed as well as traditional multivariate regression. Copyright © 2016 John Wiley & Sons, Ltd.

Elucidating the role of clofazimine for the treatment of tuberculosis.

Clofazimine (CFZ), a riminophenazine and a key component of the treatment regimen for lepromatous leprosy, has been rehabilitated clinically for the treatment of multidrug-resistant tuberculosis (MDR-TB). Observational studies and a randomized control trial suggest efficacy in the treatment of MDR-TB and the potential for treatment shortening. Animal and translational research have shown mixed results. In this article, we review key clinical, animal, and translational data to better understand the potential role of CFZ in the treatment of MDR-TB and in shortening anti-tuberculosis treatment.

Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.

Elimination of leprosy cannot be achieved by multidrug therapy alone, and new tools are needed to prevent leprosy. A randomized controlled trial with chemoprophylaxis for contacts of leprosy patients using a single dose of rifampicin (SDR) has shown an overall protective effect of approximately 60%, effective in the first 2 years after the intervention. When a contact who previously received bacillus Calmette-Guérin (BCG) vaccination also receives SDR, the protective effect is additive, approximating 80%. Vaccine trials have been conducted with BCG, often in combination with Mycobacterium leprae or related Mycobacterium vaccines as immunoprophylaxis for contacts of leprosy patients, with BCG giving the best results. Meta-analysis shows that the protective effect of BCG vaccination is larger in observational studies than in trials, 60% versus 41%, and is higher among contacts of leprosy patients than among the general population, 68% versus 53%. We believe that a future leprosy control strategy should include contact management, consisting of a contact survey, at which time preventive interventions could be added, such as chemoprophylaxis and immunoprophylaxis. Modeling studies have shown that both interventions will lower the incidence of leprosy in the population. Implementation studies of such contact-based strategy are now called for.

Prevalencia y pronóstico de la lepra en Pinar del Río

La lepra es una enfermedad infecciosa crónica, granulomatosa, transmisible, poco contagiosa, causada por el bacilo Mycobacterium leprae, que afecta principalmente la piel, los nervios periféricos, la mucosa de las vías respiratorias superiores, los ojos y otras estructuras. El objetivo fue estimar la prevalencia real a partir del cálculo de la prevalencia oculta y el pronóstico de la lepra en Pinar del Río para el 2013. Se realizó un estudio observacional descriptivo de carácter prospectivo, para la obtención de la información se revisaron las tarjetas de declaración obligatoria y las encuestas epidemiológicas de los casos de lepra. Se calcularon diferentes indicadores: tasa de prevalencia de lepra, la prevalencia oculta y el pronóstico de la enfermedad por el método de alisamiento exponencial. La prevalencia de la lepra en la provincia en los últimos años tiene una tendencia al descenso, existiendo una diferencia entre la prevalencia conocida y la prevalencia real, al incrementarse esta última con la sumatoria de la prevalencia oculta que fue de 5 casos, con un pronóstico para la enfermedad para el 2013, similar al año anterior. El estudios reveló que aunque la lepra no constituye un problema de salud en la provincia, existen brechas en el sistema de vigilancia, que se identifican con el calculo del estimado de la prevalecía oculta que representa el número de casos de lepra, que no se diagnosticaron en la provincia en los últimos cinco años, lo que influirá en los indicadores operacionales y epidemiológicos del programa de lepra(AU)

Leprosy is a chronic, mildly contagious granulomatous disease caused by the bacillus Mycobacterium leprae, affecting chiefly the skin, the peripheral nerves, the mucosa of the upper respiratory tracts, the eyes and other structures.Objective: to estimate the real prevalence by the calculation of the hidden prevalence and the prognosis of leprosy in Pinar del Río for the year 2013. An observational descriptive study of prospective character was carried out; for obtaining the information, compulsory declaration cards and the epidemiological surveys of the leprosy cases were reviewed. Several indicators were calculated: leprosy prevalence rate, hidden prevalence, and the prognosis of the disease by the method of exponential smoothing. In the last years, the prevalence of leprosy in P. Rio has a tendency towards decrease, existing a difference between the known prevalence and the real prevalence, on the increase of the latter to the sum of the hidden prevalence of 5 cases, with a forecast in the disease for 2013 similar to the previous year. The study revealed that although leprosy does not constitute a health problem in the Province, there are gaps in the surveillance system, identified after calculation of the estimate of hidden prevalence representing the number of leprosy cases, not diagnosed in the Province in the last five years, which will have an influence in the operational and epidemiological indicators of the leprosy program(AU)